Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Veng-Pedersen

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|October 1, 1995
Duration of opioid antagonism by nalmefene and naloxone in the dog. A nonparametric pharmacodynamic comparison based on generalized cross-validated spline estimationJ A Wilhelm, P Veng-Pedersen, T B Zakszewski, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1992
A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studiesJ A Widness, R L Schmidt, P Veng-Pedersen, et al.
Pharmaceutical Research|February 1, 1994
Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approachN B Modi, P Veng-Pedersen, D E Wurster, et al.
International Journal of Laboratory Hematology|April 22, 2008
The effect of anticoagulant, storage temperature and dilution on cord blood hematology parameters over timeK J Freise, R L Schmidt, E L Gingerich, et al.
Pharmaceutical Research|January 1, 1992
Surface characterization of activated charcoal by X-ray photoelectron spectroscopy (XPS): correlation with phenobarbital adsorption dataG M Burke, D E Wurster, M J Berg, et al.
Biopharmaceutics & Drug Disposition|August 10, 1999
A comparison of nonlinear pharmacokinetics of erythropoietin in sheep and humansP Veng-Pedersen, J A Widness, L M Pereira, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Developmental differences in erythropoietin pharmacokinetics: increased clearance and distribution in fetal and neonatal sheepJ A Widness, P Veng-Pedersen, N B Modi, et al.
Pharmaceutical Research|March 1, 1988
Phenobarbital adsorption from simulated intestinal fluid, U.S.P., and simulated gastric fluid, U.S.P., by two activated charcoalsD E Wurster, G M Burke, M J Berg, et al.
Journal of Pharmaceutical Sciences|June 1, 1995
Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis. Application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humansP Veng-Pedersen, J A Widness, L M Pereira, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1996
Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effectsJ A Widness, P Veng-Pedersen, C Peters, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
International Journal of Clinical Pharmacology and Therapeutics|October 1, 1995
Duration of opioid antagonism by nalmefene and naloxone in the dog. A nonparametric pharmacodynamic comparison based on generalized cross-validated spline estimationJ A Wilhelm, P Veng-Pedersen, T B Zakszewski, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1992
A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studiesJ A Widness, R L Schmidt, P Veng-Pedersen, et al.
Pharmaceutical Research|February 1, 1994
Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approachN B Modi, P Veng-Pedersen, D E Wurster, et al.
International Journal of Laboratory Hematology|April 22, 2008
The effect of anticoagulant, storage temperature and dilution on cord blood hematology parameters over timeK J Freise, R L Schmidt, E L Gingerich, et al.
Pharmaceutical Research|January 1, 1992
Surface characterization of activated charcoal by X-ray photoelectron spectroscopy (XPS): correlation with phenobarbital adsorption dataG M Burke, D E Wurster, M J Berg, et al.
Biopharmaceutics & Drug Disposition|August 10, 1999
A comparison of nonlinear pharmacokinetics of erythropoietin in sheep and humansP Veng-Pedersen, J A Widness, L M Pereira, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Developmental differences in erythropoietin pharmacokinetics: increased clearance and distribution in fetal and neonatal sheepJ A Widness, P Veng-Pedersen, N B Modi, et al.
Pharmaceutical Research|March 1, 1988
Phenobarbital adsorption from simulated intestinal fluid, U.S.P., and simulated gastric fluid, U.S.P., by two activated charcoalsD E Wurster, G M Burke, M J Berg, et al.
Journal of Pharmaceutical Sciences|June 1, 1995
Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis. Application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humansP Veng-Pedersen, J A Widness, L M Pereira, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1996
Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effectsJ A Widness, P Veng-Pedersen, C Peters, et al.
Pageof 11